IsoRay (ISR) Stock Quote

Detailed Quote for IsoRay (ISR)

close 52 Week Information

52 Week High

February 14, 2011

Close: 1.57

52 Week Low

February 1, 2012

Close: 0.60

Today

Last Price
0.71

Change $
0.021

Change %
2.87%

Tick
N/A

Bid
0.66

Bid Size
1,100

Ask
N/A

Ask Size
0

Open
0.78

High
0.78

Low
0.71

Prev Close
0.731

Last Trade
4:00

Volume
40.99 k

52 Wk Hi
1.57

52 Wk Low
0.60

Market Cap
20.81 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
29,316,306

EPS (TTM)
-0.11

PE Ratio
N/A

close Exchange Information Listed On NYSE Amex Equities Exchange (AMX) Exchange
AMX

News and Media for IsoRay (ISR)

Sector News | Topic News

News for ISR

Tue, Feb 07, 2012

8:07 AM

IsoRay Applauds Cleveland Clinic Prostate Study Conclusions on Brachytherapy Superiority - Business Wire

Mon, Dec 05, 2011

10:08 AM

IsoRay, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com - PR Newswire

Fri, Dec 02, 2011

8:32 PM

WestPark Capital, Inc., WestPark Capital, Announces $2.6 Million IsoRay Offering - PR Newswire

9:30 AM

WestPark Capital Announces $2.6 Million IsoRay Offering - PR Newswire

Tue, Nov 29, 2011

10:08 AM

IsoRay, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st - PR Newswire

10:03 AM

CEOs Present and Take Questions Live, Online, December 1st at RetailInvestorConferences.com - PR Newswire

Mon, Nov 28, 2011

7:53 AM

IsoRay Ships First GliaSite® Brain Cancer Treatment - Business Wire

Tue, Nov 22, 2011

7:47 AM

IsoRay Receives Final Regulatory Approval for GliaSite® Brain Cancer Treatment - Business Wire

More News for ISR >>

Tags for IsoRay

Research stocks or mutual funds related to IsoRay by keywords or tags. Find companies that have a similar focus to ISR. The keywords below have been associated to ISR by either user submission or electronic means.

radiation therapy side effects computer radiation radiation exposure compensation act radiation exposure corporate governance quotient problem prostate investor relations company prevent enlarged prostate prostate cancer treatment option prostate men prostate test radiation audit corporate governance consulting oil and gas stocks analyst reports strata oil and gas corporate governance training investment firm oil drillers prostate treatment prostate cancer therapy prostate surgery prostate cancer facts terahertz radiation advanced prostate cancer oil and gas leasing cesium carbonate financial information prostate faq radiation therapy prostate nuclear radiation corporate governance committee charter financial investments prostate enlargement shrink prostate prostate brachytherapy history of radiation therapy natural gas pain in prostate prostate biopsy oil & gas accounting corporate governance cancer clinical prostate trial prostate cancer radiation therapy radiation protection product radiation danger corporate governance practices oil production prostate herbal cesium chloride price